Skip to main content

Advertisement

ADVERTISEMENT

From the Experts

Clinical Update
05/20/2023

Marc P. Bonaca, MD, MPH

Executive Director, CPC Clinical Research and CPC Community Health; Director of Vascular Research and Associate Professor of Medicine, Department of Medicine, Division of Cardiovascular Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado

Marc P. Bonaca, MD, MPH Executive Di...
The phase 3 VOYAGER PAD trial demonstrated the benefit of rivaroxaban (Xarelto, Janssen Pharmaceutical Companies of Johnson & Johnson) (2.5 mg twice daily + aspirin 100 mg once daily) in reducing severe vascular events in peripheral artery...
The phase 3 VOYAGER PAD trial demonstrated the benefit of rivaroxaban (Xarelto, Janssen Pharmaceutical Companies of Johnson & Johnson) (2.5 mg twice daily + aspirin 100 mg once daily) in reducing severe vascular events in peripheral artery...
The phase 3 VOYAGER PAD trial...
05/20/2023
Cath Lab Digest
Cath Lab Management
02/02/2023

Amy Newell, Senior Vice President; Michael Church, Director
 

Corazon, Inc., offers strategic program development for the heart, vascular, neuro, and orthopedic specialties. Corazon provides a full continuum of consulting, software solution, recruitment, and interim management services for hospitals, health systems and practices of all sizes across the country and in Canada.

To learn more, visit corazoninc.com or call (412) 364-8200.  Amy Newell, Senior Vice President, can be contacted at anewell@corazoninc.com. Michael Church, Director, can be contacted at mchurch@corazoninc.com.

Amy Newell, Senior Vice President; Mi...
Healthcare’s continued focus on preventative medicine, combined with the shift of an abundant number of procedures to an outpatient setting of care, has created an environment where CPCs can be a driving force for the productivity and...
Healthcare’s continued focus on preventative medicine, combined with the shift of an abundant number of procedures to an outpatient setting of care, has created an environment where CPCs can be a driving force for the productivity and...
Healthcare’s continued focus on...
02/02/2023
Cath Lab Digest
Cath Lab Management
01/23/2023

Mariann Lannon, BSN, RN-BC, Coordinator, Heart & Vascular Program;

Sandra Page, MBA, CLSSGB, Director, Invasive Heart & Vascular Services;

Dana Lada, BSN, RN, CCRN, Clinical Data Specialist;

Willis Wu, MD, FACC, Interventional Cardiology, Director, Structural Heart Program

Reprinted with permission from EP Lab Digest Oct 2022; 22(10): 21-25.


Editor’s Note: This article has been updated by the authors since its original publication.

Mariann Lannon, BSN, RN-BC, Coordinat...
With the NCDR LAAO Registry, UNC Health Rex maintains an A rating for proportion of successful LAAO procedures, among many other data-driven metrics.
With the NCDR LAAO Registry, UNC Health Rex maintains an A rating for proportion of successful LAAO procedures, among many other data-driven metrics.
With the NCDR LAAO Registry, UNC...
01/23/2023
Cath Lab Digest
Cath Lab Management
01/15/2023

W.R. Stables1; B. Patel2; A. Patwala3; A. Hogarth4; R.H. Stables5

 

1CareCube Solutions Limited, Solihull, West Midlands; 2Lancashire Cardiac Centre, Blackpool Victoria Hospital, Blackpool; 3Royal Stoke University Hospital, Stoke-on-Trent; 4Leeds Teaching Hospitals NHS Trust, Leeds; 5Ice Cap Research Group, Liverpool Heart and Chest Hospital NHS Foundation Trust, Liverpool, United Kingdom

 

The authors can be contacted via Professor R. H. Stables at rod.stables@lhch.nhs.uk

W.R. Stables1; B. Patel2; A. Patwala3...
Contemporary cardiovascular care involves the performance of a range of procedures performed in cardiac catheterization laboratory (cath lab) facilities, akin to operating theatres. We performed a retrospective study to examine the...
Contemporary cardiovascular care involves the performance of a range of procedures performed in cardiac catheterization laboratory (cath lab) facilities, akin to operating theatres. We performed a retrospective study to examine the...
Contemporary cardiovascular care...
01/15/2023
Cath Lab Digest
Clinical Update
01/10/2023

Jennifer A. Tremmel, MD, MS

 

Associate Professor of Medicine (Cardiovascular Medicine), Susan P. and Riley P. Bechtel Medical Director of Women’s Heart Health, and Director, CTO Program, Stanford University Medical Center, Stanford, California

 

Jennifer A. Tremmel, MD, MS, FSCAI, can be contacted at jtremmel@stanford.edu

If you are located in the eastern half of the United States and are interested in learning more about the Microvascular Network, contact Dr. Henry via CLD's managing editor Rebecca Kapur at rkapur@hmpglobal.com. If you are located the western half of the U.S., please contact Dr. Tremmel at jtremmel@stanford.edu.

Jennifer A. Tremmel, MD, MS   Assoc...
Dr. Jennifer Tremmel discusses identifying and treating patients with ANOCA (also referred to as ischemia with nonobstructive coronary arteries [INOCA]), and her role as Co-Director of the Microvascular Network along with Dr. Tim Henry.
Dr. Jennifer Tremmel discusses identifying and treating patients with ANOCA (also referred to as ischemia with nonobstructive coronary arteries [INOCA]), and her role as Co-Director of the Microvascular Network along with Dr. Tim Henry.
Dr. Jennifer Tremmel discusses...
01/10/2023
Cath Lab Digest
Clinical Trial Update
01/03/2023

With A Farber, M Menard, K Rosenfield: The trial co-PIs talk with CLD.


Alik Farber, MD, MBA, Chief of the Division of Vascular and Endovascular Surgery at Boston Medical Center and Professor of Surgery and Radiology at Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts;

 

Matthew Menard, MD, Co-Director of the Endovascular Surgery Program at Brigham and Women’s Hospital; Associate Professor of Surgery, Harvard Medical School, Boston, Massachusetts;

 

Kenneth Rosenfield, MD, Head of the Section of Vascular Medicine and Intervention in the Division of Cardiology at Massachusetts General Hospital, Boston, Massachusetts.

With A Farber, M Menard, K Rosenfield...
Both surgical bypass and endovascular revascularization are considered standard-of-care treatment for patients with chronic limb-threatening ischemia (CLTI), but it has remained largely unknown which treatment approach leads to better...
Both surgical bypass and endovascular revascularization are considered standard-of-care treatment for patients with chronic limb-threatening ischemia (CLTI), but it has remained largely unknown which treatment approach leads to better...
Both surgical bypass and...
01/03/2023
Cath Lab Digest
Clinical Update
12/01/2022

CLD talks with:

• ARCH Trial Senior Investigator Professor R. H. Stables, MA (Cantab) DM Oxon BM BCh (Oxon) FRCP (London);

• STAT2 Trial Principal Investigators Jordan G. Safirstein, MD, and Arnold H. Seto, MD, MPA.

CLD talks with: • ARCH Trial Senior ...
Not only does StatSeal achieve hemostasis in less time, but it did so in a remarkably consistent manner across the entire population. We can be certain that we will not have hemostasis problems by two hours and confidently use an expedited...
Not only does StatSeal achieve hemostasis in less time, but it did so in a remarkably consistent manner across the entire population. We can be certain that we will not have hemostasis problems by two hours and confidently use an expedited...
Not only does StatSeal achieve...
12/01/2022
Cath Lab Digest
Clinical Update
10/27/2022

Richard Casazza, MAS, RT(R)(CI)

 

Maimonides Medical Center, Brooklyn, New York

Richard Casazza, MAS, RT(R)(CI)   M...
While the right distal radial artery approach is still teetering on the verge of popularity (or obscurity), it remains to be seen if operators will take up this approach as a primary access point.
While the right distal radial artery approach is still teetering on the verge of popularity (or obscurity), it remains to be seen if operators will take up this approach as a primary access point.
While the right distal radial...
10/27/2022
Cath Lab Digest
Calcium Corner
09/06/2022

Jaikirshan J. Khatri, MD, FACC, FSCAI

Director of Complex Coronary Intervention
Heart, Vascular & Thoracic Institute, Cleveland Clinic; Cleveland, Ohio

Jaikirshan J. Khatri, MD, FACC, FSCAI...
Dr. Khatri is the Director of Complex Coronary Intervention at Cleveland Clinic, performing 150-200 chronic total occlusion (CTO) procedures annually, along with a high volume of complex and high-risk coronary intervention procedures (CHIP).
Dr. Khatri is the Director of Complex Coronary Intervention at Cleveland Clinic, performing 150-200 chronic total occlusion (CTO) procedures annually, along with a high volume of complex and high-risk coronary intervention procedures (CHIP).
Dr. Khatri is the Director of...
09/06/2022
Cath Lab Digest
Calcium Corner
08/01/2022

CLD talks with Suzanne J. Baron, MD, MSc, FSCAI

CLD talks with Suzanne J. Baron, MD, ...
Since we know that inadequate lesion preparation may lead to higher rates of in-stent restenosis and stent thrombosis, it follows that intravascular lithotripsy (IVL) could help lower suboptimal PCI rates in both men and women.
Since we know that inadequate lesion preparation may lead to higher rates of in-stent restenosis and stent thrombosis, it follows that intravascular lithotripsy (IVL) could help lower suboptimal PCI rates in both men and women.
Since we know that inadequate...
08/01/2022
Cath Lab Digest

Advertisement

Advertisement

Advertisement